Comparing two antibiotics for sepsis in critical illness
Treatments studied
Part of Infections clinical trials.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis (a life-threatening infection that causes organ damage) or septic shock
- You are critically ill, needing a breathing machine, high-flow oxygen, or blood pressure support
- You have not already received more than 24 hours of meropenem or piperacillin/tazobactam for this infection
- You are not allergic to penicillin-type antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This study looks at how different types of sepsis affect treatment with the antibiotic piperacillin/tazobactam in patients with severe pneumonia. Researchers hope to find better ways to treat each person based on their specific condition.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.